International Edition
Latest News
Technology

Samsung Medical Center Launches AI Chatbot for PICC Chemotherapy Patients

Samsung Medical Center Launches KakaoTalk AI Chatbot for Cancer Patients Managing PICC Lines Samsung Medical Center’s Cancer Hospital has rolled out a KakaoTalk AI chatbot designed to help patients manage peripherally inserted central catheter (PICC) lines at home,…

Samsung Medical Center Launches AI Chatbot for PICC Chemotherapy Patients

Samsung Medical Center Launches KakaoTalk AI Chatbot for Cancer Patients Managing PICC Lines

Samsung Medical Center’s Cancer Hospital has rolled out a KakaoTalk AI chatbot designed to help patients manage peripherally inserted central catheter (PICC) lines at home, the hospital announced on February 26. The AI tool targets patients undergoing chemotherapy who carry the medical tubing for months, guiding them through potential complications like blockages and infections.

PICC lines route strong chemotherapy drugs directly into large veins near the heart via the arm. While essential for long-term treatments that risk skin damage, living with the lines introduces daily maintenance challenges. To address this, the hospital built the KakaoTalk-integrated chatbot using artificial intelligence to handle common patient inquiries remotely.

Six Core Care Categories and Visual Guides

The chatbot organizes guidance around six distinct clinical areas based on actual phone consultation data. Patients and caregivers can access troubleshooting steps for catheter management, general symptoms, insertion site abnormalities, heparin injections, daily routines, and emergency room visits.

Text descriptions alone often fall short for medical device maintenance, so the service includes instructional photos and videos for complex tasks. If a user asks a question outside the chatbot’s programmed scope, the system avoids guesswork and directs them to hospital contact details for direct medical staff consultation.

High Patient Satisfaction Rates Recorded

Initial deployment data released by the hospital show strong user reception among early adopters. In a hospital-administered survey of patients who used the chatbot, 96% reported satisfaction with the service. Furthermore, 100% of surveyed users indicated they would recommend the AI tool to other patients.

“Patients with PICC lines feel anxious about even small changes, but they didn’t have anywhere to ask questions at night or on the weekends,” said Kim Hee-chul, director of the cancer hospital and a colorectal surgery professor. He added that the institution will continuously evaluate chatbot usage rates, patient satisfaction, and shifts in medical utilization to refine the service moving forward.

About the author: Anika Shah - Technology

MSc in Computer Science, senior reporter. Anika focuses on AI ethics, cybersecurity, and emerging hardware—frequently moderating panels at CES and Web Summit. “Anika Shah decodes tech breakthroughs and startup disruption shaping tomorrow’s digital landscape.”